Stocks in news: ZEE, M&M Financial, Dr Reddy's, Wipro, Biocon
Domestic markets rally on exit polls predicting Modi government's massive mandate. ZEE, M&M Financial, Dr Reddy's, Wipro, Biocon in focus. ZEE to discuss fundraising. M&M Financial reports increased disbursements. Dr Reddy's opens biologics facility in Hyderabad. ICICI Bank partners with Adani One for co-branded credit cards with airport-linked benefits. RVNL awarded Rs 440 crore project by South Central Railway.
Domestic markets have seen a one sided , taking heart from the exit polls which have predicted a massive mandate for the once again. In today's trade, of , M&M Financial, , , among others will be in focus today due to various developments.ZEE
The Board of will meet on June 6 to consider and approve a fundraising proposal through issue of equity or any other securities.
M&M Financial
M&M Financial said its May overall disbursements were up 7% in May, while collection efficiency was at 96% for the reporting month.
Dr Reddy's
Dr Reddy's Labs arm opened its biologics facility offering process development and clinical scale manufacturing capabilities in Hyderabad.
ICICI Bank has partnered with Adani One launched a co-branded credit cards with airport-linked benefits.
Wipro
Wipro has appointed Bruno Schenk as Country Head & Managing Director for Switzerland, effective immediately.
RVNL has received a letter of acceptance for a project worth Rs 440 crore from South Central Railway.
Biocon
Biocon said it secured approval from for its vertically integrated, complex injectable product micafungin.
M&M Financial
M&M Financial said its May overall disbursements were up 7% in May, while collection efficiency was at 96% for the reporting month.
Dr Reddy's
Dr Reddy's Labs arm opened its biologics facility offering process development and clinical scale manufacturing capabilities in Hyderabad.
ICICI Bank has partnered with Adani One launched a co-branded credit cards with airport-linked benefits.
Wipro
Wipro has appointed Bruno Schenk as Country Head & Managing Director for Switzerland, effective immediately.
RVNL has received a letter of acceptance for a project worth Rs 440 crore from South Central Railway.
Biocon
Biocon said it secured approval from for its vertically integrated, complex injectable product micafungin.
Poll Trackers
Source: Stocks-Markets-Economic Times
